The Patent Finder

Bresagen Limited

Also on record
Records under this name other than patents Bresagen Limited holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Bresagen Limited

PatentTitleStatus Expires Confidence
US 8,334,138Methods and compositions for feeder-free pluripotent stem cell media containing human serum
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,623,650Methods and compositions for feeder-free pluripotent stem cell media containing human serum
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 7,432,104Methods for the culture of human embryonic stem cells on human feeder cells
Formerly held
Lapsed on the fee record
Ended Oct 7, 2020 · From the USPTO record
Lapsed on the fee recordEnded Oct 7, 2020From the USPTO record
US 7,737,253Human cancer stem cell culture compositions comprising Erbb2 variants and methods of use thereof
Formerly held
Lapsed on the fee record
Ended Jun 15, 2018 · From the USPTO record
Lapsed on the fee recordEnded Jun 15, 2018From the USPTO record
US 7,445,931Compositions and Methods for Enrichment of Neural Stem Cells Using Ceramide Analogs
Formerly held
Lapsed on the fee record
Ended Nov 4, 2016 · High confidence
Lapsed on the fee recordEnded Nov 4, 2016High confidence
US 7,201,899Materials and methods for management of hyperacute rejection in human xenotransplantation
Term ended
Term ended Jan 28, 2015 · From the USPTO record
Term endedTerm ended Jan 28, 2015From the USPTO record
US 6,849,448Pigs and pig cells having an inactivated α 1,3-galactosyl transferase gene
Term ended
Term ended Jan 27, 2014 · From the USPTO record
Term endedTerm ended Jan 27, 2014From the USPTO record
US 6,749,833Design and planning system for improving the survival rate of injected structures
Formerly held
Lapsed on the fee record
Ended Jun 15, 2012 · From the USPTO record
Lapsed on the fee recordEnded Jun 15, 2012From the USPTO record
US 6,994,841Relating to magnetic resonance imaging
Formerly held
Term ended
Ended no later than Mar 9, 2010 · From the USPTO record
Term endedEnded no later than Mar 9, 2010From the USPTO record
US 6,465,616Interleukin-5 antagonist
Lapsed on the fee record
Ended Oct 15, 2006 · From the USPTO record
Lapsed on the fee recordEnded Oct 15, 2006From the USPTO record
10 of 15 patents shown.
Pro members see all 15.
Pro members: see all 15 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited